Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer

NCT07066969 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07066969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07066969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 22, 2026
Completion date
April 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer